Skip to main content

Abstract

Many psychomotor signs and symptoms are influenced by the activity of dopaminergic neurons and by drugs that selectively interact with neuronal dopamine receptors. These include rigidity in Parkinson’s disease, hallucinations in schizophrenia and Alzheimer’s disease, dyskinesia in Huntington’s chorea, and spontaneous oral dyskinesia in the elderly (Seeman, 1987; Seeman et al., 1987; Seeman and Niznik, 1990). These receptors may also play a significant role in drug addiction and alcoholism (Blum et al., 1990). On the basis of pharmacological, biochemical, and physiological criteria, receptors for dopamine have been classified into two types, termed D1 and D2 (Kebabian and Calne, 1979; Seeman, 1980; Niznik and Jarvie, 1989). These are members of a large gene family of hormone/neurotransmitter receptors that exert their biological actions via signal transduction pathways that involve guanine nucleotide-binding proteins. While D2 dopamine receptors inhibit the activation of adenylyl cyclase and appear to couple to numerous other effector systems, D1 dopamine receptors, found in the brain, retina, and parathyroid gland, stimulate adenylyl cyclase and subsequently activate cAMP-dependent protein kinases (Niznik, 1987; Seeman and Niznik, 1988; Hess and Creese, 1987; Hemmings et al., 1987).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Andersen PH, Gingrich J A, Bates MD, Dearry A, Falardeau P, Senogles SE, Caron MG (1990): Dopamine receptor subtypes: Beyond the D1/D2 classification. Trends Pharmacol Sci 11: 231–236

    Article  Google Scholar 

  • Ashkenazi A, Ramachandran J, Capon DJ (1989): ACH analogue stimulate DNA synthesis in brain cells via specific muscarinic receptor subtypes. Nature 340: 146–150

    Article  Google Scholar 

  • Basset AS, McGilvray BC, Jones BD, Pantzar JT (1988): Partial trisomy of chromosome 5 cosegregating with schizophrenia. Lancet i: 799–801

    Google Scholar 

  • Benovic JL, Deblasi A, Stone WC, Caron MG, Lefkowitz RJ (1989): ß-Adrenergic receptor kinase: Primary structure delineates a multigene family. Science 246: 235–246

    Article  Google Scholar 

  • Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jagadeeswarran P, Nogami H, Briggs AH, Cohn JB (1990): Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 263: 2055–2060

    Article  Google Scholar 

  • Brown EM, Chen CJ, Niznik HB, Fogel EL, Hawkins D (1989): Control of parathyroid function by dopamine: Characterization of D1 receptors and their interaction with other secretagogues in bovine parathyroid cells. In: Peripheral Dopamine Pathophysiology, Amenta F, ed. Boca Raton, Florida: CRC Press, pp 99–116

    Google Scholar 

  • Bunzow JR, Van Tol HHM, Grandy DK, Albert P, Salon J, Christie M, Machida CA, Neve KA, Civelli O (1988): Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 336: 783–787

    Article  Google Scholar 

  • Clark D, White FJ (1987): D1 dopamine receptor — the search for a function. Synapse 1: 347–388

    Article  Google Scholar 

  • Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A, Shivers BD, Seeberg PH (1989): The dopamine D2 receptor: Two molecular forms generated by alternative splicing. EMBO J 8 (13): 4025–4034

    Google Scholar 

  • Dearry AG, Gingrich JA, Falardeau P, Fremeau RT, Bates MD, Caron MG (1990): Molecular cloning and expression of the gene for a human D1 dopamine receptor. Nature 347: 72–76

    Article  Google Scholar 

  • Detera-Wadleigh DDD, Goldin LR, Sherrington R, Encio I, de Miiguel C, Berrettini W, Gurling H, Gershon ES (1989): Exclusion of linkage to 5qll-13 in families with schizophrenia and other psychiatric disorders. Nature 340: 391–393

    Article  Google Scholar 

  • Felder RA, Felder CC, Eisner GM, Jose PA (1989): The dopamine receptor in adult and maturing kidney. Am J Physiol 257: F315–F327

    Google Scholar 

  • Gilliam TC, Freimer NB, Kaufman CA, Powchik PP, Basset AS, Bengtsson U, Wasmuth J J (1989): Deletion mapping of DNA markers to a region of chromosome 5 that co-segregates with schizophrenia. Genomics 5: 940–944

    Article  Google Scholar 

  • Grandy DK, Marchionni MA, Makam H, Stofko RE, Alfano M, Frothingham L, Fischer JB, Burke-Howie KJ, Bunzow JR, Server AC, Civelli, O (1989): Cloning of the cDNA and gene for a human D2 dopamine receptor. Proc Natl Acad Sci USA 86: 9762–9766

    Article  Google Scholar 

  • Grandy DK, Zhou QY, Allen L, Litt R, Magenis E, Civelli O, Litt M (1990): A human D1 dopamine receptor gene is located on chromosome 5 at q35.1 and identifies an Eco R1 RFLP. Amer J Hum Genet 47: 828–834

    Google Scholar 

  • Gutkind C, Novotny E, Brann MR, Robbins K (1991): Muscarinic receptors as agonist dependent oncogenes. Proc Natl Acad Sci USA 88: 1459–1463

    Article  Google Scholar 

  • Hartmann E, Rapoport TA, Lodish HF (1989): Predicting the orientation of eukaryotic membrane spanning proteins. Proc Natl Acad Sci USA 86: 5786–5790

    Article  Google Scholar 

  • Hemmings HC, Walaas SI, Oiumet CC, Greengard P (1987): Dopaminergic regulation of protein phosphorylation in the striatum: DARP-32. Trends Neurosci 10: 77–82

    Article  Google Scholar 

  • Hess EJ, Creese I (1987): Biochemical characterization of dopamine receptors. In Receptor Biochemistry and Methodology: Dopamine Receptors, Creese I, Fraser CM, New York: Liss, Vol 8, pp 57–71

    Google Scholar 

  • Jarvie KR, Booth G, Brown EM, Niznik HB (1989): Glycoprotein Nature of dopamine D1 receptors. Mol Pharmacol 34: 566–574

    Google Scholar 

  • Kebabian JW, Calne DB (1979): Multiple receptors for dopamine. Nature 277: 93–96

    Article  Google Scholar 

  • Kennedy JL, Giuffra LA, Moises HW, Cavalli-Sforza LL, Pakstis AJ, Kidd JR, Castiglione CM, Sjogren B, Wetterberg L, Kidd KK (1988): Evidence against linkage of schizophrenia to markers on chromosome 5 in a northern Swedish kindred. Nature 336: 167–170

    Article  Google Scholar 

  • Kobilka BK, Frielle T, Dohlman HG, Bolanowski MA, Dixon RAF, Keller P, Caron MG, Lefkowitz RJ (1987): Delineation of the intronless Nature of the genes for the human and hamster ß2-adrenergic receptor and their putative promoter regions. J Biol Chem 262 (15): 7321–7327

    Google Scholar 

  • Lankford KL, Demello FG, and Klein WL (1988): D1 type dopamine receptors inhibit growth cone motility in cultured retinal neurons: Evidence that neurotransmitters act as morphogenic regulators in the developing nervous system. Proc Natl Acad Sci USA 85: 2839–2843

    Article  Google Scholar 

  • Mahan LC, Burch RM, Monsma FJ, Sibley DR (1990): Expression of striatal D1 dopamine receptors coupled to inositolphosphate production and calcium mobilization in Xenopus oocytes. Proc Natl Acad Sci USA 87: 2196–2200

    Article  Google Scholar 

  • Mengod G, Vilaro MT, Niznik HB, Sunahara RK, Seeman P, O’Dowd BF, Palacios JM (1991): Visualization of a dopamine D1 receptor mRNA in human and rat brain. Mol Brain Res 10: 185–191

    Article  Google Scholar 

  • Niznik HB (1987): Dopamine receptors; molecular structure and function. Mol Cell Endocrinol 54: 1–22

    Article  Google Scholar 

  • Niznik HB, Fogel EL, Chen CJ, Congo D, Brown EM, Seeman P (1988a): Dopamine D1 receptors of the calf parathyroid gland; Identification and characterization. Mol Pharmacol 34: 29–36

    Google Scholar 

  • Niznik HB, Jarvie KR, Bzowej NH, Seeman P, Garlick RK, Miller JJ, Baindur N, Neumeyer JL (1988b): Photoaffinity labeling of dopamine D1 receptors. Biochemistry 27: 7594–7599

    Article  Google Scholar 

  • Niznik HB, Jarvie KR (1989): Dopamine receptors. In: Receptor Pharmacology and Function, Williams M, Glennon RA, Timmermans PBMWM eds. New York: Dekker, pp 717–768

    Google Scholar 

  • Niznik HB, Jarvie KR, Brown EM (1989): Dopamine D1 receptors of the calf parathyroid gland: Identification of a ligand binding subunit with lower apparent molecular weight but similar primary structure to neuronal D1 receptors. Biochemistry 28: 6925–6930

    Article  Google Scholar 

  • O’Dowd BF, Hnatowich M, Regan JW, Leader WM, Caron MG, Lefkowitz RJ (1988): Site directed mutagenesis of the cytoplasmic domains of the human ß2-adrenergic receptor. J Biol Chem 263: 15985–15992

    Google Scholar 

  • O’Dowd BF, Lefkowitz RJ, Caron MG (1989a): Structure of the adrenergic and related receptors. Annu Rev Neurosci 12: 67–83

    Article  Google Scholar 

  • O’Dowd BF, Hnatowich M, Caron MG, Lefkowitz RJ, Bouvier M (1989b): Palmitoylation of the human ß-adrenergic receptor: Mutation of cys341 in the carboxy tail leads to an uncoupled nonpalmitylated form of the receptor. J Biol Chem 264 (13): 7564–7569

    Google Scholar 

  • O’Dowd BF, Nguyen T, Tirpak A, Jarvie KR, Israel Y, Seeman P, Niznik HB (1990): Cloning of two additional catecholamine receptors from rat brain. FEBS Lett 262: 8–12

    Article  Google Scholar 

  • O’Dowd BF, Hnatowich M, Lefkowitz RJ (1991a): Adrenergic and related G protein coupled receptors: Structure and function. Encycl Hum Biol 1: 81–92

    Google Scholar 

  • O’Dowd BF, Nguyen T, Jin H, Grupp L, Seeman P (1991b): Two human pseudogenes homologous to the D5 dopamine receptors. Abstr Neurosci Soc 17: 598

    Google Scholar 

  • Ovchinnikov YA, Abdulaev NG, Bogachuk AS (1988): Two adjacent cysteine residues in the c-terminal cytoplasmic fragment of bovine rhodopsin are palmitylated. FEBS Lett 230: 1–5

    Article  Google Scholar 

  • Seeman P (1980): Dopamine receptors. Pharmacol Rev 32: 229–313

    Google Scholar 

  • Seeman P (1987): Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1: 133–152

    Article  Google Scholar 

  • Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, Riederer P, Jellinger K, Tourtellotte WW (1987): Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer’s, Parkinson’s and Huntington’s diseases. Neuropsychopharmacology 1: 5–15

    Article  Google Scholar 

  • Seeman P, Niznik HB (1988): Dopamine D1 receptor pharmacology. ISI Atlas Sci: Pharmacol 2: 161–170

    Google Scholar 

  • Seeman P, Niznik HB, Guan HC, Booth G, Ulpian C (1989): Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain. Proc Natl Acad Sci USA 86: 10156–10160

    Article  Google Scholar 

  • Seeman P, Niznik HB (1990): Dopamine receptors and transporters in Parkinson’s disease and schizophrenia. FASEB/4: 2737–2744

    Google Scholar 

  • Sherrington R, Brynjolfsson J, Petursson H, Potter M, Dudleston K, Barraclough B, Wasmuth J, Dobbs M, Gurling H (1988): Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature 336: 164–167

    Article  Google Scholar 

  • Sokoloff P, Giros B, Martes MP, Bouthenet ML, Schwartz JC (1990): Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347: 146–151

    Article  Google Scholar 

  • Stormann TM, Gdula P, Weiner DM, Brann MR (1990): Molecular cloning and expression of a dopamine D2 receptor from human retina. Mol Pharmacol 37: 1–6

    Google Scholar 

  • Strader CD, Sigal IS, Register RB, Candelore MR, Rands E, Dixon RAF (1987): Identification of residues required for ligand binding to the ß-adrenergic receptor. Proc Natl Acad Sci USA 84: 4384–4388

    Article  Google Scholar 

  • Strader CD, Candelore MR, Hill WS, Sigal IS, Dixon RAF (1989a): Identification of two serine residues involved in agonist activation of the ß-adrenergic receptor. J Biol Chem 264: 13572–13578

    Google Scholar 

  • Strader CD, Sigal IS, Dixon RAF (1989b): Structural basis of ß-adrenergic receptor function. FASEB J 3: 1825–1832

    Google Scholar 

  • Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL, Gelerntner JL, Rozmahel R, Yang Y, Israel Y, Seeman P, O’Dowd BF (1990): Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature 347: 80–83

    Article  Google Scholar 

  • Sunahara RK, Guan H-C, O’Dowd BF, Seeman P, Laurier LG, Ng G, George SR, Torchia J, Van Toi HHM, Niznik HB (1991): Cloning a human dopamine receptor gene (D5) with higher affinity for dopamine than Dl. Nature 350: 614–619

    Article  Google Scholar 

  • Van Toi HHM, Bunzow JR, Guan HG, Sunahara RK, Seeman P, Niznik HB, Civelli O (1991): Cloning a human dopamine D4 receptor gene with high affinity for the antipsychotic clozapine. Nature 350: 610 - 614

    Article  Google Scholar 

  • Waddington JL (1989): Functional interactions between Dl and D2 dopamine receptor systems. J Psychopharmacol 3: 54–63

    Article  Google Scholar 

  • Waddington JL, O’Boyle KM (1989): Drug acting on dopamine receptors: A conceptual réévaluation five years after the first selective Dl antagonist. Pharmacol Ther 43: 1–52

    Google Scholar 

  • Weiner DM, Brann MR (1989): The distribution of dopamine D2 receptor mRNA in rat brain. FEBS Lett 253: 207–213

    Article  Google Scholar 

  • Weiner DM, Levey AI, Sunahara RK, Niznik HB, O’Dowd BF, Brann MR (1991): Dopamine Dl and D2 receptor mRNA expression in rat brain. Proc Natl Acad Sci USA 88: 1859–1863

    Article  Google Scholar 

  • Yang-Feng TL, Fhong XF, Cotecchia S, Frielle T, Caron MG, Lefkowitz RJ (1990): Chromosomal organization of adrenergic receptor genes. Proc Natl Acad Sci USA 87: 1516–1520

    Article  Google Scholar 

  • Zhou QY, Grandy DK, Thambi L, Kushner JA, Van Toi HHM, Cone R, Pribnow D, Salon J, Bunzow JR, Civelli O (1990): Cloning and the expression of human and rat Dl dopamine receptors. Nature 347: 76–80

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Birkhäuser Boston

About this chapter

Cite this chapter

Niznik, H.B. et al. (1992). The Dopamine D1 Receptors. In: Brann, M.R. (eds) Molecular Biology of G-Protein-Coupled Receptors. Applications of Molecular Genetics to Pharmacology. Birkhäuser Boston. https://doi.org/10.1007/978-1-4684-6772-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-6772-7_6

  • Publisher Name: Birkhäuser Boston

  • Print ISBN: 978-1-4684-6774-1

  • Online ISBN: 978-1-4684-6772-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics